Circ_0000285 Regulates Proliferation, Migration, Invasion and Apoptosis of Osteosarcoma by MiR-409-3p/IGFBP3 Axis

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2020 Oct 12

PMID 33041662

Citations 26

Authors

Zhisheng Long

Feipeng Gong

Yuxu Li

Zhiqiang Fan

Jingtang Li

Affiliations

Soon will be listed here.

Abstract

Background: Circular RNAs (circRNAs) are important regulators in the pathogenesis of diseases and affects the occurrence and development of diseases. However, the role of circRNAs in osteosarcoma (OS) has not been fully elucidated.

Methods: The expression of circ_0000285, miR-409-3p and insulin-like growth factor binding protein 3 (IGFBP3) was detected using quantitative real-time PCR (qRT-PCR). The protein level of IGFBP3 was measured using western blot. CCK-8 and colony formation assays were used to determine cell proliferation. Flow cytometry was applied to measure cell cycle and cell apoptosis. Transwell assay was used to assess cell invasion and migration. Dual-luciferase reporter assay and RNA Binding Protein Immunoprecipitation (RIP) assay were performed to determine the relationship among circ_0000285, miR-409-3p and IGFBP3. The animal experiments were performed to determine the function of circ_0000285 in vivo.

Results: In this study, we found that the expression of circ_0000285 was significantly increased in OS tissues and cells and was enriched in the cytoplasm. Knockdown of circ_0000285 inhibited OS growth in vitro and in vivo. Moreover, miR-409-3p was a target miRNA of circ_0000285 and miR-409-3p targets to IGFBP3 in OS. Besides, circ_0000285 could promote proliferation, migration, invasion and inhibit apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis.

Conclusion: In this study, circ_0000285 regulated proliferation, migration, invasion and apoptosis of OS cells by miR-409-3p/IGFBP3 axis, implying that circ_0000285 was a potential target for OS therapy.

Citing Articles

MicroRNAs and hypospadias: A systematic review.

Amoushahi M, Jorgensen P, Kjeldgaard A, Padi E, Fossum M Med Int (Lond). 2024; 5(1):7.

PMID: 39624466 PMC: 11609889. DOI: 10.3892/mi.2024.206.

Cross-talk between circRNAs and m6A modifications in solid tumors.

Liu F, Gu W, Shao Y J Transl Med. 2024; 22(1):694.

PMID: 39075555 PMC: 11288061. DOI: 10.1186/s12967-024-05500-4.

Osteosarcoma in a ceRNET perspective.

Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.

PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.

Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review).

Xie W, Wang Z, Wang J, Wang X, Guan H Int J Oncol. 2024; 65(1).

PMID: 38757364 PMC: 11155714. DOI: 10.3892/ijo.2024.5655.

CircAGFG1 Promotes Ovarian Cancer Progression Through the miR-409-3 p/ZEB1 Axis.

Luo J, Zhong H, Guo M, Xiao P, Cao R, Zhao M Technol Cancer Res Treat. 2024; 23:15330338241252423.

PMID: 38752261 PMC: 11102704. DOI: 10.1177/15330338241252423.

References

Simpson E, Brown H . Understanding osteosarcomas. JAAPA. 2018; 31(8):15-19. DOI: 10.1097/01.JAA.0000541477.24116.8d. View

Jin X, Feng C, Xiang Z, Chen Y, Li Y . CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis. Oncotarget. 2016; 7(41):66455-66467. PMC: 5341813. DOI: 10.18632/oncotarget.12186. View

Deivendran S, Marzook H, Santhoshkumar T, Kumar R, Pillai M . Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer. Sci Rep. 2017; 7:44225. PMC: 5385551. DOI: 10.1038/srep44225. View

Kong Z, Wan X, Zhang Y, Zhang P, Zhang Y, Zhang X . Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2017; 493(3):1217-1223. DOI: 10.1016/j.bbrc.2017.07.162. View

Bao L, Liu H, You B, Gu M, Shi S, Shan Y . Overexpression of IGFBP3 is associated with poor prognosis and tumor metastasis in nasopharyngeal carcinoma. Tumour Biol. 2016; 37(11):15043-15052. DOI: 10.1007/s13277-016-5400-8. View

Kansara M, Teng M, Smyth M, Thomas D . Translational biology of osteosarcoma. Nat Rev Cancer. 2014; 14(11):722-35. DOI: 10.1038/nrc3838. View

Lu M, Wu Y, Zeng B, Sun J, Li Y, Luo J . CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis. Biochem Biophys Res Commun. 2020; 526(2):306-313. DOI: 10.1016/j.bbrc.2020.03.084. View

Yin H, Zhang S, Sun Y, Li S, Ning Y, Dong Y . MicroRNA-34/449 targets IGFBP-3 and attenuates airway remodeling by suppressing Nur77-mediated autophagy. Cell Death Dis. 2017; 8(8):e2998. PMC: 5596548. DOI: 10.1038/cddis.2017.357. View

Zhang J, Hou W, Jia J, Zhao Y, Zhao B . MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma. FEBS Open Bio. 2017; 7(3):348-357. PMC: 5337891. DOI: 10.1002/2211-5463.12177. View

10.

Cao G, Sun X, Wu F, Chen W, Li J, Hu W . Low expression of miR-409-3p is a prognostic marker for breast cancer. Eur Rev Med Pharmacol Sci. 2016; 20(18):3825-3829. View

11.

El Tayebi H, Waly A, Assal R, Hosny K, Esmat G, Abdelaziz A . Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma. Oncol Lett. 2016; 10(5):3206-3212. PMC: 4665895. DOI: 10.3892/ol.2015.3725. View

12.

Tan Y, Chen L, Li S, Hao H, Zhang D . MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3. Technol Cancer Res Treat. 2020; 19:1533033820909125. PMC: 7057399. DOI: 10.1177/1533033820909125. View

13.

Qin J, Chang W, Yuan G, Huang L, Qiu Z . Circular RNA hsa_circ_0000285 acts as an oncogene in laryngocarcinoma by inducing Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019; 23(24):10803-10809. DOI: 10.26355/eurrev_201912_19783. View

14.

Zhang G, Liu Z, Xu H, Yang Q . miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1. Biochem Biophys Res Commun. 2015; 469(2):189-95. DOI: 10.1016/j.bbrc.2015.11.099. View

15.

Li S, Gu H, Huang Y, Peng Q, Zhou R, Yi P . Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling. Cell Cycle. 2018; 17(19-20):2349-2359. PMC: 6237437. DOI: 10.1080/15384101.2018.1526599. View

16.

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

17.

Liu Y, Dong Y, Zhao L, Su L, Luo J . Circular RNA‑MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis. Int J Oncol. 2018; 53(4):1752-1762. DOI: 10.3892/ijo.2018.4485. View

18.

Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

19.

Palmerini E, Torricelli E, Cascinu S, Pierini M, De Paolis M, Donati D . Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?. Pediatr Blood Cancer. 2019; 66(8):e27792. DOI: 10.1002/pbc.27792. View

20.

Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L . circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017; 36(32):4551-4561. PMC: 5558096. DOI: 10.1038/onc.2017.89. View